Clinical Trial

Melatonin for Post Tonsillectomy Emergence Agitation in Pediatric

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if melatonin can decrease emergence agitation in pediatric post tonsillectomy. The main questions it aims to answer are: Does melatonin decrease emergence agitation in pediatric post tonsillectomy? What medical problems do participants have when taking melatonin? Researchers will compare melatonin to a placebo (a look-alike substance that contains no drug) to see if melatonin works todecrease emergence agitation in pediatric post tonsillectomy Participants will receive Oral melatonin at a dose of 0.5 mg/kg (maximum 20 mg) administered 30 minutes before induction of anesthesia. Dose chosen based on prior pediatric studies and safety data.
Protocol Amendment History 2 changes
critical Trial status changed: Enrolling by Invitation → Recruiting 2026-07-19
minor Completion pushed: 2026-06-01 -> 2026-08-01 2026-07-19
Trial Details
NCT Number NCT07375342
Lead Sponsor Benha University
Conditions Post Tonsillectomy Emergence Agitation
Enrollment 120 participants
Start Date 2025-12-10
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-17